Exploring the present to provide you with the keys to the future

Publications - 25 Nov 2021

Continuing applications : pointers for european applicants on creating US patent portfolio

By

Publications - 28 Oct 2021

Patentability of dosage requirements: towards an easing of requirements in canada

By

Publications - 28 Oct 2021

Post-published evidence and inventive step: confirmed referral to the EPO’s Enlarged Board of Appeal (case G2/21)

By

Publications - 06 Oct 2021

Patentability of in vitro diagnostic methods in Canada: A favorable evolution!

By

Publications - 09 Sep 2021

How to assess patent quality ? (2/2)

By

Publications - 14 Jul 2021

More revoked patents in the CRISPR/Cas9 saga: The plot thickens

By

Publications - 12 Jul 2021

European patents with unitary effect | Unified Patent Court: Toward a start in the first half 2022 ?

By

Publications - 06 Jul 2021

Antibodies defined by functional features: Beware of sufficiency of disclosure !

By

Publications - 09 Jun 2021

EPO : a new Decision facilitates EP patent prosecution for applicants claiming priority in People’s Republic of China

By

Publications - 09 Jun 2021

Mediation? A real strategic choice !

By

Publications - 01 Jun 2021

How to assess patent quality ?

By

Publications - 19 May 2021

Brazil: End of the extension of patent validity and special regime for the pharmaceutical sector

By